Pharmacy numbers dropped from 11,522 in 2022 to 11,414 in 2023, and a further 436 closed this year in 2024. As numbers ...

Join us for live coverage of JP Morgan Healthcare Conference, where life sciences leaders congregate in San Francisco to ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

"Clinical evidence suggests that the AI technologies may improve fracture detection on X‑rays in urgent care without ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

It comes after Mangione was previously charged with the lesser charge of second-degree murder, as well as possession of an unlicensed firearm, forgery, and providing false identification to police.

Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related breathing disorder that is most common in people who are overweight and ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

In a new report, ‘Helping others: unlocking the potential of ‘other’ cancers through predictive analytics’, the Concr team – co-founders Matthew Foster and Matthew Griffiths, together ...